---
name: Genelife Clinical Research Pvt. Ltd.
slug: genelifecr
site: cro
website_domain: genelifecr.com
summary: CDSCO-registered CRO in India running Phase I–IV trials, real world evidence studies, and bioequivalence (BABE) studies for pharma, biotech, and device sponsors. Offices in Mumbai, California, Cambridge, and Hamburg support multi-regional programs. Headquartered in Mumbai, India.
tagline: CDSCO-registered CRO in India offering Phase I–IV, RWE, and regulatory services
founded_year: 2010
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: IN
tier2_domain_verified: false
updated_at: 2026-11-22T07:02:22.709Z
services_count: 13
modalities_count: 4
indications_count: 4
locations_count: 4
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Genelife Clinical Research Pvt. Ltd.

CDSCO-registered CRO in India offering Phase I–IV, RWE, and regulatory services

Listed on cro.directory.

## Summary

CDSCO-registered CRO in India running Phase I–IV trials, real world evidence studies, and bioequivalence (BABE) studies for pharma, biotech, and device sponsors. Offices in Mumbai, California, Cambridge, and Hamburg support multi-regional programs. Headquartered in Mumbai, India.

## At a glance

- Founded: 2010
- HQ country: IN

## Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Central Laboratory Services
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy

## Modalities

- Small Molecule
- Biologics (Other)
- Peptide
- Vaccine

## Indications

- Oncology
- Neurology
- Cardiovascular
- Dermatology

## Locations

- Mumbai, India (Headquarters), Mumbai, India
- Carson, California, Carson, California, USA
- Cambridge, UK, Cambridge, United Kingdom
- Hamburg, Germany, Hamburg, Germany

## Certifications

- CDSCO; Identifier: CRO/MH/2026/000159; Source: https://genelifecr.com/about-us

## Long description

## Overview

Genelife Clinical Research Pvt. Ltd. is a Clinical Research Organization headquartered in Mumbai, India, founded in 2010. The company is registered with the Central Drugs Standard Control Organisation (CDSCO) under Registration No. CRO/MH/2026/000159.

## Services

- Clinical operations, including site management, monitoring, and project management
- Phase I–IV clinical trials and Real World Evidence studies
- Regulatory affairs, including IND, NDA, and ANDA submissions for CDSCO, FDA, and EMA
- Pharmacovigilance, including SAE reporting, signal detection, and CTD Module II preparation
- Data management with EDC and CDISC compliance
- Biostatistics, including ICH E9-aligned analysis, SAP development, and PK/PD analysis
- Medical writing for protocols, CSRs, IBs, and DSURs
- Bioavailability/bioequivalence (BABE) study support
- Quality assurance, including GCP audits and inspection readiness
- Epidemiology and disease surveillance to support feasibility and site selection

## Therapeutic and Product Focus

The company reports work across biologics (including biosimilars, recombinant peptides, vaccines, and adenoviral vector delivery systems), medical devices, small molecule drugs, and oncology, cardiology, and CNS programs. It also lists cosmeceutical and nutraceutical study support.

## Global Presence

Genelife operates offices in Mumbai (India), Carson, California (USA), Cambridge (UK), and Hamburg (Germany). The company states it works with sponsors across multiple continents.

## Similar companies

- [Innovate Research](/companies/innovate-research) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/genelifecr/innovate-research)
- [MMS Holdings](/companies/mmsholdings) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/genelifecr/mmsholdings)
- [Clario](/companies/clario) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/clario/genelifecr)
- [Fortrea](/companies/fortrea) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/fortrea/genelifecr)
- [TFS HealthScience](/companies/tfscro) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/genelifecr/tfscro)
- [Signant Health](/companies/signanthealth) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/genelifecr/signanthealth)
- [Accelsiors](/companies/accelsiors) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/accelsiors/genelifecr)
- [Velocity Clinical Research](/companies/velocityclinical) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/genelifecr/velocityclinical)

_Profile last updated: 2026-11-22T07:02:22.709Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.